Orexo AB: insider trades · Finland · FIN-FSA FI:orexo-ab-9629af SE0000736415 FI FI · FIN-FSA Mcap 647M€ Healthcare
Discover the full insider trade history of Orexo AB, a listed issuer based in Finland. Shares are quoted on FI FI, under the supervision of FIN-FSA. Operating in the Healthcare sector, Orexo AB has published 4 insider filings. Market capitalisation: €647m. The latest transaction was disclosed on 4 September 2025 — Purchase. Among the most active insiders: Nikolaj Arrild Sørensen. All data is openly available.
Financial data FY ended December 2025 · cache
Analyst consensus
1 analysts · 27.00 € Target 27.00 €(+47%) 27.00 €
Income statement
Revenue 26.0 M€
Gross profit 11.5 M€ 44% margin
Net income 639.3 M€ 2928.7% margin
Valuation
PER (forward) -2.6x
P/Book 1.8x
Beta 0.87
Balance sheet & cash
Market cap 647.0 M€
Total debt 491.5 M€
Free Cash Flow −195.4 M€
Debt / Equity 2%
Profitability & ownership
ROE -410.9%
ROA -38.0%
% insiders 18.9%
% institutions 40.3%
Last declaration on 4 September 2025
Declarations 4 total
Executives ● Purchase37 FIN-FSA
06 shares 0SE0000736415⌘
Aktie
FI:A003S047-1 · 2 Sept 2025
Ideal exit: 30 May 2026 (T+270) Executives ● Purchase8 FIN-FSA
R
Robert dElUCA Annan medlem i bolagets administrations-, lednings- eller kontrollorgan 01 shares 0US68616W1027⌘
Aktie
FI:A003S008-1 · 2 Sept 2025
Ideal exit: 30 May 2026 (T+270) Executives ● Purchase8 FIN-FSA
R
Robert dElUCA Annan medlem i bolagets administrations-, lednings- eller kontrollorgan 03,493 shares 0US68616W1027⌘
Aktie
FI:A003P105-1 · 28 May 2025
Ideal exit: 22 Feb 2026 (T+270) Executives ● Purchase31 FIN-FSA
€41,096 30,108 shares @ €1.365 0.0064% mcap 100.0% of flow SE0000736415⌘
Aktie
FI:A003O679-1 · 19 May 2025
Ideal exit: 13 Feb 2026 (T+270)